Administration of Afala in urological practice


Citar

Texto integral

Resumo

Our studies of afala in patients with prostatic adenoma demonstrate that afala reduces irritative disorders of urination. Effect of this drug is seen in 98.3% patients during 4 weeks of its use. In longer intake the effect becomes stronger. The dose of 6 tablets a day significantly improves life quality. Three times a day dose is more effective in elimination of nicturia, enhances urine flow rate. Thus, choice of afala dose depends on the symptoms. Afala is indicated for prophylaxis in patients with initial stage of prostatic adenoma and as an alternative to expectation policy.

Bibliografia

  1. Catalona W. J., Smith D. S., Ratliff T. L. et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991; 324 (17): 1156-1161.
  2. Takayama T. K., Vessella R. L., Lange P. H. Never applications of serum prostate-specific antigen in the management of prostate cancer. Semin. Oncol. 1994; 21 (5): 542-553.
  3. Пушкарь Д. Ю., Раснер П. И. Медикаментозная профилактика рака предстательной железы. Онкоурология 2008; 2: 73-77.
  4. Яковец Е. А. Роль регулятора активности инсулиноподобного фактора роста в комплексной терапии больных ДГП. В кн.: Современные вопросы урологии, андрологии, репродуктивной медицины: Материалы VII Межрегиональной конф. Новосибирск; 2008. 348-351.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2009

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies